キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/20 | 2,502 | 2,543 | 2,502 | 2,534 | +29 | +1.2% | 29,200 |
2023/01/19 | 2,519 | 2,545 | 2,500 | 2,505 | -14 | -0.6% | 33,700 |
2023/01/18 | 2,481 | 2,523 | 2,481 | 2,519 | +42 | +1.7% | 50,000 |
2023/01/17 | 2,462 | 2,480 | 2,457 | 2,477 | +15 | +0.6% | 27,300 |
2023/01/16 | 2,431 | 2,472 | 2,431 | 2,462 | +13 | +0.5% | 28,100 |
2023/01/13 | 2,457 | 2,482 | 2,444 | 2,449 | -16 | -0.6% | 50,000 |
2023/01/12 | 2,459 | 2,485 | 2,456 | 2,465 | +6 | +0.2% | 42,700 |
2023/01/11 | 2,459 | 2,503 | 2,459 | 2,459 | +6 | +0.2% | 51,400 |
2023/01/10 | 2,467 | 2,503 | 2,452 | 2,453 | -12 | -0.5% | 45,000 |
2023/01/06 | 2,484 | 2,492 | 2,456 | 2,465 | -22 | -0.9% | 45,700 |
2023/01/05 | 2,513 | 2,524 | 2,485 | 2,487 | -37 | -1.5% | 64,200 |
2023/01/04 | 2,550 | 2,553 | 2,498 | 2,524 | -56 | -2.2% | 53,600 |
2022/12/30 | 2,603 | 2,615 | 2,575 | 2,580 | -23 | -0.9% | 42,800 |
2022/12/29 | 2,562 | 2,604 | 2,556 | 2,603 | +19 | +0.7% | 32,300 |
2022/12/28 | 2,550 | 2,594 | 2,533 | 2,584 | +23 | +0.9% | 39,400 |
2022/12/27 | 2,583 | 2,602 | 2,551 | 2,561 | -23 | -0.9% | 14,700 |
2022/12/26 | 2,600 | 2,603 | 2,573 | 2,584 | -24 | -0.9% | 38,300 |
2022/12/23 | 2,598 | 2,617 | 2,581 | 2,608 | +54 | +2.1% | 94,400 |
2022/12/22 | 2,535 | 2,554 | 2,514 | 2,554 | +32 | +1.3% | 44,800 |
2022/12/21 | 2,514 | 2,536 | 2,500 | 2,522 | +4 | +0.2% | 58,300 |
2022/12/20 | 2,528 | 2,553 | 2,496 | 2,518 | +12 | +0.5% | 73,900 |
2022/12/19 | 2,520 | 2,520 | 2,495 | 2,506 | -36 | -1.4% | 29,100 |
2022/12/16 | 2,538 | 2,554 | 2,528 | 2,542 | -17 | -0.7% | 61,400 |
2022/12/15 | 2,534 | 2,563 | 2,534 | 2,559 | +15 | +0.6% | 27,800 |
2022/12/14 | 2,527 | 2,544 | 2,525 | 2,544 | +25 | +1% | 30,100 |
2022/12/13 | 2,522 | 2,532 | 2,506 | 2,519 | +17 | +0.7% | 30,800 |
2022/12/12 | 2,461 | 2,506 | 2,458 | 2,502 | +6 | +0.2% | 45,200 |
2022/12/09 | 2,500 | 2,517 | 2,496 | 2,496 | -18 | -0.7% | 44,100 |
2022/12/08 | 2,500 | 2,518 | 2,498 | 2,514 | +15 | +0.6% | 47,800 |
2022/12/07 | 2,447 | 2,507 | 2,447 | 2,499 | +46 | +1.9% | 46,400 |
2022/12/06 | 2,460 | 2,483 | 2,451 | 2,453 | -23 | -0.9% | 71,500 |
2022/12/05 | 2,475 | 2,492 | 2,442 | 2,476 | +7 | +0.3% | 44,100 |
2022/12/02 | 2,506 | 2,506 | 2,437 | 2,469 | -52 | -2.1% | 84,700 |
2022/12/01 | 2,543 | 2,549 | 2,488 | 2,521 | -13 | -0.5% | 72,100 |
2022/11/30 | 2,546 | 2,550 | 2,517 | 2,534 | -18 | -0.7% | 103,000 |
2022/11/29 | 2,560 | 2,568 | 2,539 | 2,552 | -28 | -1.1% | 63,200 |
2022/11/28 | 2,627 | 2,627 | 2,580 | 2,580 | -32 | -1.2% | 45,500 |
2022/11/25 | 2,587 | 2,623 | 2,587 | 2,612 | +11 | +0.4% | 45,600 |
2022/11/24 | 2,594 | 2,622 | 2,573 | 2,601 | +48 | +1.9% | 60,900 |
2022/11/22 | 2,525 | 2,565 | 2,517 | 2,553 | +40 | +1.6% | 53,500 |
2022/11/21 | 2,502 | 2,520 | 2,498 | 2,513 | +11 | +0.4% | 34,500 |
2022/11/18 | 2,495 | 2,504 | 2,484 | 2,502 | +41 | +1.7% | 51,500 |
2022/11/17 | 2,438 | 2,461 | 2,433 | 2,461 | +44 | +1.8% | 58,200 |
2022/11/16 | 2,404 | 2,428 | 2,404 | 2,417 | -5 | -0.2% | 23,500 |
2022/11/15 | 2,416 | 2,441 | 2,415 | 2,422 | +22 | +0.9% | 34,700 |
2022/11/14 | 2,420 | 2,425 | 2,399 | 2,400 | -44 | -1.8% | 59,800 |
2022/11/11 | 2,476 | 2,480 | 2,420 | 2,444 | +18 | +0.7% | 54,100 |
2022/11/10 | 2,427 | 2,457 | 2,410 | 2,426 | -1 | ±0% | 76,500 |
2022/11/09 | 2,485 | 2,514 | 2,413 | 2,427 | -108 | -4.3% | 114,800 |
2022/11/08 | 2,552 | 2,560 | 2,531 | 2,535 | -4 | -0.2% | 47,100 |
651~
700
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム